Results 131 to 140 of about 230,179 (219)

Phenotyping Overactive Bladder – Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Management of overactive bladder (OAB) has a stepwise approach in adults and children. This does not account for individual patient variations, which may explain suboptimal outcomes in many patients. Distinct OAB profiles, based on patient characteristics, symptoms, urodynamic findings and imaging have been discussed in Part 1 ...
Michel Wyndaele, Michael Samarinas, Apostolos Apostolidis, D. Carolina Ochoa, Giovanni Mosiello, Brigitte Schurch, Pradeep Tyagi, Alan Wein, Paul Abrams, John E. Speich   +9 more
wiley   +1 more source

Correction: Assessment of urate-lowering therapies on lipid metabolism and kidney function in nondialysis chronic kidney disease patients: 12 months multicenter cohort study. [PDF]

Front Endocrinol (Lausanne)
Waheed YA, Yin H, Liu J, Almayahe S, Bishdary M, Selvam KKM, Farrukh SM, Li S, Wang D, Zhou X, Sun D.   +10 more
europepmc   +1 more source

β3‐Adrenoceptor Agonists for Neurogenic Lower Urinary Tract Dysfunction: Evidence and Clinical Rationale for First‐Line Therapy

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley   +1 more source

Supplementum 294: Abstracts of the 57th Annual meeting of the Swiss Society of Nephrology (Interlaken, Switzerland, December 4−5, 2025)

Swiss Medical Weekly
Swiss Society of Nephrology
doaj   +1 more source

Correction: Gender-specific assessment of lipid profiles correlation with serum uric acid in non-dialysis chronic kidney disease patients: prospective observational cross-sectional study. [PDF]

Front Endocrinol (Lausanne)
Waheed YA, Yin H, Liu J, Almayahe S, Bishdary M, Selvam KKM, Farrukh SM, Li S, Wang Y, Wang D, Zhou X, Sun D.   +11 more
europepmc   +1 more source

Should We Consider Sacral Nerve Stimulation as a Treatment for Neurogenic Lower Urinary Tract Dysfunction? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To explore the boundary of clinical use of sacral nerve stimulation (SNS) in neurogenic lower urinary tract dysfunction (NLUTD), identifying barriers to approval and early‐impact research questions. Methods This review is derived from a proposal discussion at the International Consultation on Incontinence‐Research Society in Bristol in ...
Marcus J. Drake, Mathijs de Rijk, Stefania Musco, Jalesh Panicker, Michał Późniak, Nikita Bhatt, Brigitte Schurch   +6 more
wiley   +1 more source

Association between lipoprotein combine index and all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis: a multicenter retrospective cohort study. [PDF]

Front Nutr
Yan C, Zhan Q, Xu Q, Peng F, Wen Y, Tian N, Wang X, Feng X, Wu X, Wu J, Su N, Tang X, Zhou Q, Lu J, Chen Y, Zhan X.   +15 more
europepmc   +1 more source

Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported.
Jalesh N. Panicker, Chris Harding, Hashim Hashim, Claire Hentzen, Nikita Bhatt, Arjun Nambiar, Brigitte Schurch, Mathijs de Rijk, Stefania Musco   +8 more
wiley   +1 more source

AI-assisted Qualitative Research on Kidney Failure Treatment Decisions. [PDF]

Transplantation
Bicki A, Rojas GA, Ku E.
europepmc   +1 more source

What Is Required for AI to Improve the Assessment and Treatment of Patients With Lower Urinary Tract Dysfunction? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Artificial intelligence (AI) is poised to improve the diagnosis and management of lower urinary tract dysfunction (LUTD). Its effective deployment requires prioritization, regulatory oversight, rigorous validation, and clinician and patient engagement.
Glenn T. Werneburg, Michel Wyndaele, John E. Speich, Enrico Finazzi Agro, Mo Belal, Sachin Malde, George Bou Kheir, Emre Huri, Arjun K. Nambiar, Giovanni Mosiello, Riccardo Lombardo, Phil Toozs‐Hobson, Christopher R. Chapple, Alan J. Wein, Paul Abrams, Kevin Rademakers   +15 more
wiley   +1 more source